Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited - fmcg in Delhi, India. FY 2026 financials & compliance.
CIN U51101DL2007PTC165275 Incorporated 27 June 2007 ROC Delhi HQ Delhi, India
Active Private Limited Company FMCG
Data last updated
Revenue · FY 2025
₹52.25 Cr
▲ 6% YoY
Net profit · FY 2025
₹3.5 Cr
Net margin 6.7%
EBITDA · FY 2025
₹7.5 Cr
EBITDA margin 14.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹13.2 Cr
Satisfied ₹16.58 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
130
Provident fund records

About Ambe Phytoextracts Private Limited

Data last updated:

Ambe Phytoextracts Private Limited is a private limited company based in Delhi, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 27 June 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2007PTC165275. Its GSTIN is 07AAGCA4375B1ZY (Delhi). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Harsh Pal Singh (Managing Director) and Beena Singh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 202 Ifuna Cghsl Plot No.55 Balco Market Ip Extension Patparganj, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.25 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.5 Cr (net margin 6.7%) and EBITDA of ₹7.5 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.

The company has about 130 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Ambe Phytoextracts. As per MCA filings, the company has open charges of ₹13.2 Cr and satisfied charges of ₹16.58 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Radhey Bio. Tech Private Limited. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 36 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ambe-group.com.

Company Details of Ambe Phytoextracts Private Limited
CIN U51101DL2007PTC165275
Registration Number 165275
Incorporation Date 27 June 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    D – 202 Ifuna Cghsl Plot No.55 Balco Market Ip Extension Patparganj, Delhi, India – 110092
  • Industry
    FMCG, Personal Care & Skincare Products
Comprehensive company report
Ambe Phytoextracts Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Ambe Phytoextracts Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ambe Phytoextracts Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Ambe Phytoextracts Private Limited

The main business activities of Ambe Phytoextracts are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Ambe Phytoextracts Private Limited FY 2025 filings available

Ambe Phytoextracts Private Limited reported revenue of ₹52.25 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹52.25 Cr ▲ 6%
Net profit · FY 2025
₹3.5 Cr margin 6.7%
EBITDA · FY 2025
₹7.5 Cr margin 14.4%

Compounded Annual Growth Rate (CAGR) of Ambe Phytoextracts Private Limited

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 5%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 17%
5 years · compounded
▲ 16%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 6% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Ambe Phytoextracts Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹7.5 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹3.5 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Ambe Phytoextracts Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14.4%••••••••••••••••
Net Profit Margin6.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ambe Phytoextracts are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Radhey Bio. Tech Private Limited••••••••••••••••-Gurgaon, Haryana, India
Halcyon Labs Private Limited••••••••••••••••79Mumbai, Maharashtra, India
Flax Laboratories Private Limited••••••••••••••••-Mahad, Maharashtra, India
Vani Pharma Labs Limited••••••••••••••••-Hyderabad, Telangana, India
Om Biomedic Private Limited••••••••••••••••-Hisar, Haryana, India
Ambe Phytoextracts Private Limited this company••••••••••••••••-Delhi, India
Unilab Chemicals and Pharmaceuticals Private Limited••••••••••••••••-Mumbai, Maharashtra, India
Vincit Labs Private Limited••••••••••••••••-New Delhi, Delhi, India
K. A. Malle Pharmaceuticals Limited••••••••••••••••-Mumbai, Maharashtra, India
Ranq Remedies Private Limited••••••••••••••••49Thane (West), Maharashtra, India
Salvavidas Pharmaceutical Private Limited••••••••••••••••63Surat City, Gujarat, India

Peers are the five companies nearest above and the five nearest below Ambe Phytoextracts by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited is audited by NARENDER SINGH & CO. for the financial year 2023.

NameStatusAppointment DateCessation Date
NARENDER SINGH & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Ambe Phytoextracts Private Limited

Ambe Phytoextracts has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harsh Pal SinghManaging Director27 Jun 200719 Years 3 MonthsCurrent
Renu RawatDirector22 Jan 20197 Years 8 MonthsCurrent
Beena SinghWhole-Time Director27 Jun 200719 Years 3 MonthsCurrent

Ownership and Shareholding of Ambe Phytoextracts Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ambe Phytoextracts Private Limited

Open charges
₹13.2 Cr
Satisfied charges
₹16.58 Cr
Breakdown by lending institutions
Yes Bank Limited₹12.82 Cr
Others₹0.18 Cr
Hdb Financial Services Limited₹0.11 Cr
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateLenderAmountStatus
10 Jun 2025Hdb Financial Services Limited₹10.6 LakhOpen
27 Jun 2024Yes Bank Limited₹12.82 CrOpen
15 Sep 2023Others₹9.6 LakhOpen
30 Sep 2022Others₹8.36 LakhOpen
22 Jun 2021Hdfc Bank Limited₹9.89 LakhOpen

Total charge records: 15 View all charges

Deals & Funding of Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010.

Total deals
1
Funding round
1
Disclosed funding
₹40 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2010Funding round₹40 Lakh
Premium access

Full deal history

All 1 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 36 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 36)

SupplierAmount dueDue sinceReported on
an individual supplier••••••••••••
an individual supplier••••••••••••
Amar Polyfils Pvt Ltd••••••••••••
an individual supplier••••••••••••
an individual supplier••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Ambe Phytoextracts Private Limited

Ambe Phytoextracts operates one associated brand: Ambe Phytoextracts. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of natural ingredients and extracts for healthcare, FMCG, and personal care.ambe-group.com

Employees and EPFO Compliance at Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited has a workforce of 130 employees as of Apr 07, 2024.

Employee count
130
Active EPFO establishments
2
Employee growth
-16.67%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Muskan Choudhary ceased to be Director on 31 Jan 2024.

AGM
Ambe Phytoextracts Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdb Financial Services Limited amounted to Rs. 10.60 Lakh with Charge ID 101136732 was registered on 10 Jun 2025.
Filing
Ambe Phytoextracts Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 19 Dec 2020 via Charge ID 100410086 with Axis Bank Limited was fully satisfied on 22 Oct 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 1,282.00 Lakh with Charge ID 100958047 was registered on 27 Jun 2024.
Charges
A charge registered on 23 Jun 2021 via Charge ID 100474437 with Hdfc Bank Limited was fully satisfied on 12 Jun 2024.
Charges
A charge registered on 23 May 2018 via Charge ID 100183312 with Bank Of India was fully satisfied on 01 Feb 2024.
Ceased
Muskan Choudhary ceased to be Director.
Charges
A charge with Others amounted to Rs. 9.60 Lakh with Charge ID 100813598 was registered on 15 Sep 2023.
Charges
A charge registered on 13 Jun 2018 via Charge ID 100193748 with Hdfc Bank Limited was fully satisfied on 26 Jun 2023.
Charges
A charge registered on 09 Aug 2019 via Charge ID 100291570 with Bank Of India was fully satisfied on 19 Jun 2023.
Charges
A charge registered on 17 Dec 2021 via Charge ID 100517011 with Axis Bank Limited was fully satisfied on 18 Mar 2023.

24 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Ambe Phytoextracts Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ambe Phytoextracts Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Ambe Phytoextracts Private Limited

Ambe Phytoextracts has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
07AAGCA4375B1ZYDelhiActive01 Jul 2017
05AAGCA4375B1Z2UttarakhandActive01 Jul 2017
09AAGCA4375B1ZUUttar PradeshActive28 Nov 2020
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ambe Phytoextracts Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ambe Phytoextracts Private Limited

Ambe Phytoextracts is an active private limited company based in Delhi, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 27 June 2007 (19+ years old) and is registered under CIN U51101DL2007PTC165275.

Ambe Phytoextracts reported revenue of ₹52.25 Cr for FY 2025 (up 6% YoY).

Ambe Phytoextracts has 3 current directors:

Ambe Phytoextracts reported a net profit of ₹3.5 Cr (net margin 6.7%) and EBITDA of ₹7.5 Cr (EBITDA margin 14.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Ambe Phytoextracts is 5% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Ambe Phytoextracts is 07AAGCA4375B1ZY, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 05AAGCA4375B1Z2 (Uttarakhand), 09AAGCA4375B1ZU (Uttar Pradesh).

The CIN (Corporate Identification Number) of Ambe Phytoextracts is U51101DL2007PTC165275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ambe Phytoextracts has 3 court cases on record: 2 filed by the company and 1 filed against it.

Ambe Phytoextracts was incorporated on 27 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

Ambe Phytoextracts has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010.

The peers of Ambe Phytoextracts by revenue are Radhey Bio. Tech Private Limited, Halcyon Labs Private Limited, Flax Laboratories Private Limited, Vani Pharma Labs Limited, Om Biomedic Private Limited and 5 more, all in the Pharma industry (API Manufacturers).

Muskan Choudhary ceased to be Director on 31 Jan 2024. Beena Singh ceased to be Director on 01 Apr 2022. Harsh Pal Singh ceased to be Director on 01 Apr 2022. Ambe Phytoextracts has 6 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available